EGFR and neoplasm: To enhance tumor-specific targeting, recent studies have focused on conjugating ICG with NIR fluorescent dyes attached to tumor-targeting agents, such as those directed at the epidermal growth factor receptor (EGFR), which is overexpressed in 50–70% of GBM [21,88,89,90].